815
Views
0
CrossRef citations to date
0
Altmetric
Review

New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact

ORCID Icon, ORCID Icon, , &
Pages 491-502 | Received 10 Mar 2024, Accepted 07 May 2024, Published online: 22 May 2024